AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Most people accept that innovating involves risk. If a gene therapy patient dies, regulators stiffen controls, but they don't make gene therapy impossible. Similarly, the United States must apply balance in addressing business scandals. Corporate governance problems call for safeguards, but not to the point of hobbling risk taking and economic growth. As dangerous as an Enron Corp. is, even more dangerous would be a system designed to make all future Enrons impossible.
Consider the U.S. economy over the past 20 years. The bursting of the stock market's bubble followed years of corporate restructuring and innovation. Boards seeking maximum value from the changes often …